Jeffrey Strawn
Psychiatry · Cincinnati, OHNPI 1801947288
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 23.8%. 2025 is the largest year on record at $15,885, more than ten times the $442 reported in 2019. Among psychiatry clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $616.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- H. Lundbeck A S$7K
- Alkermes, Inc.$7K
- Collegium Pharmaceutical, Inc.$7K
- AbbVie$6K
- Supernus Pharmaceuticals, Inc.$2K
- Axsome Therapeutics, Inc.$269
- plus $526 from 4 others
Across 68 payments — averaging $4514.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$299K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$8K
What the payments were for
- Consulting fees$12,61142%
- Speaking & faculty fees$14,51048%
- Travel & lodging$8133%
- Food & beverage$2,1457%
- Education$1190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| H. Lundbeck A S | 1 | $7,200 |
| Alkermes, Inc. | 6 | $7,026 |
| Collegium Pharmaceutical, Inc. | 5 | $6,614 |
| AbbVie(2 entities) | 23 | $6,330 |
| Supernus Pharmaceuticals, Inc. | 6 | $2,232 |
| Axsome Therapeutics, Inc. | 3 | $269 |
| Ironshore Pharmaceuticals Inc. | 2 | $255 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $116 |
| Otsuka America Pharmaceutical, Inc. | 1 | $112 |
| Sage Therapeutics, LLC | 1 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$30,198 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 35 | $352 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Cincinnati
- Henry NasrallahCincinnati$3.8M
- Paul KeckCincinnati$739K
- Tracey SkaleCincinnati$674K
- Helen FarrellCincinnati$277K
- Caleb AdlerCincinnati$143K
- Velissarios KaracostasCincinnati$56K
- John HawkinsCincinnati$30K
- Fred RomeoColumbus$2.3M
- Amita PatelDayton$2.1M
- Pradeep ManudhaneCanton$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.